Latest Releases
Senators Smith, Shaheen Reintroduce Legislation to Protect Access to Affordable Housing for Families in Rural Areas
[Washington, DC] – This week, U.S. Tina Smith (D-MN) and Jeanne Shaheen (D-NH) reintroduced legislation to ensure that thousands of low-income tenants in rural areas are able to maintain access to safe and affordable housing. The Strategy and Investment in Rural Housing Preservation Act would protect access to affordable housing for families in rural areas that are often elderly or disabled, who are at risk of losing rental assistance through the U.S. Department of Agriculture (USDA) Rural Housing Service (RHS). “Without access to housing, nothing else in your life works. Not your job, your health, your education or your family,” said Senator Smith. “As Chair of the Subcommittee on Housing, Transportation, and Community Development, I have worked with stakeholders to expand access to affordable housing, but we also need to make sure that people who already have a place they call home can keep it that way. And that’s what this bill does. Our measure would help families and elderly Minnesotans stay in their homes.” “The pandemic exacerbated housing insecurity in New Hampshire and across the nation, and that was felt especially hard in rural communities,” said Senator Shaheen. “As Americans recover from the economic hardships of COVID-19, addressing the affordable housing crisis is pivotal. Every Granite Stater deserves to be safely housed, and it’s crucial that Congress acts now to lessen the impact of the affordable housing crisis on vulnerable families. The Strategy and Investment in Rural Housing Preservation Act would help address these obstacles by providing resources
Senator Smith Reintroduces Legislation to Provide Free Emergency Insulin on Rx Companies’ Dime
WASHINGTON [5.11.23] – This week, U.S. Senator Tina Smith (D-Minn.) reintroduced legislation to hold insulin manufacturers accountable for excessive increases in the price of life-sustaining insulin. The Emergency Access to Insulin Act would provide emergency access to insulin for people in Minnesota and across the country who can’t afford the skyrocketing price of the drug that they need to stay alive. “Over a million people are rationing their insulin so they can afford it. And sometimes, they are paying with their lives,” said Sen. Smith. “This bill will allow states to set up a program to provide insulin on an emergency basis, put insulin manufacturers on the hook by requiring them to foot the bill for these programs, hold these manufacturers accountable for gouging the price of insulin, and promote market competition to drive down the price of insulin. This bill holds the right people accountable. To the greedy practice of wielding market power to continually increase prices and make billions off a drug that has been around for over a century, this bill says—no more. This is about providing Minnesotans and Americans with the insulin they need to survive.” “We’ve seen firsthand over the last several months that the pressure we’ve put on drug companies to lower insulin costs is working, and today’s bill is the next step in our fight to make insulin affordable for every American who needs it,” said Rep. Craig. “I’m grateful to Rep. Phillips and Sen. Smith for their partnership on this important issue.”
U.S. Senator Tina Smith’s Statement on President Trump’s State of the Union Address
WASHINGTON, D.C. [02/05/2019]—This evening, U.S. Senator Tina Smith (D-Minn.) released the following statement in response to President Trump’s State of the Union Address. “I grew up with my mom always saying something that I think a lot of other Americans heard growing up—that ‘actions speak louder than words.’ We heard the President bring up bipartisanship tonight, and wouldn’t it be great if he lives up to his words,” said Sen. Smith. “His actions need to match what he shared with all of us, and one place I hope we can gain bipartisan support is my bill to help federal contract workers get
U.S. Senator Tina Smith Continues Fight to Lower Prescription Drug Prices By Backing Bipartisan Legislation to Bring Generics to Market
Senator Says Bipartisan Legislation Would Combat Brand-Name Pharmaceutical Companies Unfairly Blocking Lower-Cost Generic Drugs WASHINGTON, D.C [02/06/2019]—This week, U.S. Senator Tina Smith (D-Minn.) continued one of her top health care priorities—lowering the skyrocketing costs of prescription drugs—by supporting bipartisan legislation led by Sen. Patrick Leahy (D-Vt.) to stop brand-name pharmaceutical companies from blocking lower-cost generic drugs to market. The Creating and Restoring Equal Access To Equivalent Samples (CREATES) Act, which is also supported by Minnesota Senator Amy Klobuchar (D-Minn.), would deter pharmaceutical companies from blocking cheaper generic alternatives from entering the marketplace. “The amount of money that Americans pay for medications
U.S. Senator Tina Smith, Senate Colleagues Fight to Increase Fairness and Transparency in Lending Practices
WASHINGTON, D.C. [02/06/19]—Yesterday, U.S. Senator Tina Smith (D-Minn.) took steps to improve data collection and deter discrimination in mortgage lending. The Home Loan Quality Transparency Act would reinstate key reporting mortgage lending data reporting requirements that were repealed last year over the objections of Sen. Smith and many consumer and civil rights advocates. The new legislation to reinstate lending transparency was introduced by Sen. Cortez Masto (D-Nev.) and cosponsored by Sen. Smith. “I believe that when we have an opportunity to make our communities more inclusive, strengthen transparency, and make sure banks and lenders are playing by the rules, we should take it,” said Sen. Smith. “This legislation strengthens a key tool for
U.S. Senators Klobuchar, Smith Push to Prevent Unfair Prescription Drug Hikes
Senators Back Bill to Stop Big Pharma from Using Exclusivity Periods to Stave Off Lower-Cost Generics Coming to Market WASHINGTON, D.C. [02/07/2019]—U.S. Senators Amy Klobuchar (D-Minn.) and Tina Smith (D-Minn.) recently helped introduce legislation to help prevent price hikes for prescription drugs. Sens. Klobuchar and Smith have both traveled across the state and know just how much Minnesotans—and Americans across the country—struggle when it comes to affording the high cost of prescription medications. The Forcing Limits on Abusive and Tumultuous (FLAT) Prices Act of 2019—led by U.S. Senator Dick Durbin (D-IL) and also supported by Sens. Kamala Harris (D-CA) and Richard Blumenthal